These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11914150)

  • 1. Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
    Croft AM; Herxheimer A
    BMC Public Health; 2002 Mar; 2():6. PubMed ID: 11914150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine-induced acute hepatitis.
    Gotsman I; Azaz-Livshits T; Fridlender Z; Muszkat M; Ben-Chetrit E
    Pharmacotherapy; 2000 Dec; 20(12):1517-9. PubMed ID: 11130224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of the drugs available to prevent malaria.
    Croft AM; Whitehouse DP; Cook GC; Beer MD
    Expert Opin Drug Saf; 2002 May; 1(1):19-27. PubMed ID: 12904156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].
    Meszaros K; Kasper S
    Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass administration of the antimalarial drug mefloquine to Guantánamo detainees: a critical analysis.
    Nevin RL
    Trop Med Int Health; 2012 Oct; 17(10):1281-8. PubMed ID: 22882560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mefloquine use, psychosis, and violence: a retinoid toxicity hypothesis.
    Mawson A
    Med Sci Monit; 2013 Jul; 19():579-83. PubMed ID: 23852388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
    Frey SG; Chelo D; Kinkela MN; Djoukoue F; Tietche F; Hatz C; Weber P
    Malar J; 2010 Oct; 9():291. PubMed ID: 20964849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.
    Agomo PU; Meremikwu MM; Watila IM; Omalu IJ; Odey FA; Oguche S; Ezeiru VI; Aina OO
    Malar J; 2008 Sep; 7():172. PubMed ID: 18782445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
    Tran TM; Browning J; Dell ML
    Malar J; 2006 Aug; 5():74. PubMed ID: 16925829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report.
    Nevin RL
    Travel Med Infect Dis; 2012 May; 10(3):144-51. PubMed ID: 22494697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefloquine as a prophylaxis for malaria needs to be revisited.
    Ahmad SS; Rahi M; Ranjan V; Sharma A
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():23-26. PubMed ID: 34339933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports.
    Smith HR; Croft AM; Black MM
    Clin Exp Dermatol; 1999 Jul; 24(4):249-54. PubMed ID: 10457122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mefloquine and malaria prophylaxis.
    Drug Ther Bull; 1998 Mar; 36(3):20-2. PubMed ID: 9684417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
    Lebain P; Juliard C; Davy JP; Dollfus S
    Encephale; 2000; 26(4):67-70. PubMed ID: 11064842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute hepatitis associated with mefloquine therapy].
    Bruguera M; Herrera S
    Gastroenterol Hepatol; 2007 Feb; 30(2):102-3. PubMed ID: 17335720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.